Meeting report: Current cancer perspectives from the 9 th Annual Meeting of the Japanese Society of Medical Oncology

Thoracic Cancer

Volumn 3, Issue 1, 2012, Pages 94-97

  Nurwidya, Fariz ^a   Takahashi, Fumiyuki ^a   Takahashi, Kazuhisa ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Annual meeting; Biomarkers; Esophageal carcinoma; Lung cancer

Indexed keywords

CETUXIMAB; CISPLATIN; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; FLUOROURACIL; GEFITINIB; PEMETREXED; PLACEBO; SORAFENIB;

ADJUVANT CHEMORADIOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CHEMOEMBOLIZATION; COLORECTAL CANCER; CONFERENCE PAPER; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HUMAN; INTENSITY MODULATED RADIATION THERAPY; JAPANESE; LIVER CELL CARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; ONCOLOGY; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; SCIENTIST; THORAX CANCER;

EID: 84861398069     PISSN: 17597706     EISSN: 17597714     Source Type: Journal    
DOI: 10.1111/j.1759-7714.2011.00076.x     Document Type: Conference Paper

References (0)